Health Care & Life Sciences » Pharmaceuticals | Il-Yang Pharmaceutical Co. Ltd.

Il-Yang Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
146,461
147,732
248,380
261,615
269,811
300,036
Cost of Goods Sold (COGS) incl. D&A
91,125
90,445
141,657
143,836
139,054
151,442
Gross Income
55,336
57,286
106,723
117,779
130,757
148,595
SG&A Expense
51,092
51,521
84,325
93,240
105,374
130,171
EBIT
3,227
4,733
20,688
23,182
23,975
16,722
Unusual Expense
-
-
61
639
6,631
-
Non Operating Income/Expense
414
543
585
975
1,423
4,299
Interest Expense
6,006
5,481
6,055
5,423
4,949
4,551
Pretax Income
1,724
469
15,271
16,238
11,011
8,069
Income Tax
594
1,668
4,199
4,275
5,266
4,818
Equity in Affiliates
3,204
5,162
-
-
-
-
Consolidated Net Income
2,073
3,963
11,071
11,963
5,745
3,251
Net Income
2,073
3,963
4,823
5,906
931
4,893
Net Income After Extraordinaries
2,073
3,963
4,823
5,906
931
4,893
Net Income Available to Common
2,073
3,963
4,823
5,906
931
4,893
EPS (Basic)
119.00
227.00
264.00
317.00
50.00
269
Basic Shares Outstanding
17
17
18
19
19
18
EPS (Diluted)
119.10
227.02
263.85
316.70
50.05
269.35
Diluted Shares Outstanding
17
17
18
19
19
18
EBITDA
6,992
9,983
33,227
34,569
35,569
103,877
Other Operating Expense
1,016
1,032
1,710
1,357
1,408
1,701
Non-Operating Interest Income
641
674
114
92
40
197
Minority Interest Expense
-
-
6,248
6,057
6,677
8,144

About Il-Yang Pharmaceutical Co.

View Profile
Address
110 Hagal-ro
Yongin GY 17096
Korea, Republic Of
Employees -
Website http://www.ilyang.co.kr
Updated 07/08/2019
Il-Yang Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. Its products are medicines including ethical and over-the counter drugs under the brand names of NolTec, Supect, and Wonbi-D. The company was founded on July 1, 1946 and is headquartered in Yongin, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.